Literature DB >> 19352190

Properties of different pancreatin preparations used in pancreatic exocrine insufficiency.

Johannes-Matthias Löhr1, Frank M Hummel, Konstantinos T Pirilis, Gregor Steinkamp, Andreas Körner, Friederike Henniges.   

Abstract

BACKGROUND: Pancreatic enzyme preparations are a life-saving substitution for a pivotal physiological function of the entire organism that is impaired in chronic pancreatitis, cystic fibrosis and other diseases with exocrine pancreatic insufficiency. Pancreatic enzyme preparations, generically called pancreatin, are not alike. Rather, they present a broad variety of pancreatin composition. AIM: The properties of a set of commercially available pancreatin preparations were investigated in light of the physiological tasks such enzymes must fulfill during the normal digestive process.
METHODS: Measurements of size, surface, acid resistance, release of enzymes, pharmacokinetics and batch consistency were undertaken.
RESULTS: Although all pancreatin preparations contain the declared lipase units and are acid-stable, a wide variation was observed in the particle size (pyloric passage), specific surface area and release kinetics of lipase activity at pH 6 (duodenum).
CONCLUSION: At present, available pancreatin preparations vary widely with respect to investigated parameters, which may have consequences for facilitating optimal digestion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19352190     DOI: 10.1097/MEG.0b013e328328f414

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  11 in total

Review 1.  Diagnosis and treatment of pancreatic exocrine insufficiency.

Authors:  Björn Lindkvist
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

Review 2.  Pharmacological challenges in chronic pancreatitis.

Authors:  Anne Estrup Olesen; Anne Brokjaer; Iben Wendelboe Fisher; Isabelle Myriam Larsen
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

Review 3.  Endoscopic and Conservative Management of Chronic Pancreatitis and Its Complications.

Authors:  Alexander Waldthaler; Roberto Valente; Urban Arnelo; J-Matthias Löhr
Journal:  Visc Med       Date:  2019-04-03

Review 4.  Pancreatic enzyme therapy.

Authors:  Joachim Mössner; Volker Keim
Journal:  Dtsch Arztebl Int       Date:  2010-08-29       Impact factor: 5.594

5.  Synopsis of recent guidelines on pancreatic exocrine insufficiency.

Authors:  J-Matthias Löhr; Mark R Oliver; Luca Frulloni
Journal:  United European Gastroenterol J       Date:  2013-04       Impact factor: 4.623

Review 6.  Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century.

Authors:  Tony Trang; Johanna Chan; David Y Graham
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

7.  Mifepristone (RU486) inhibits dietary lipid digestion by antagonizing the role of glucocorticoid receptor on lipase transcription.

Authors:  Peng Ma; Yao Zhang; Qiying Liang; Youjie Yin; Saifei Wang; Ruolei Han; Chunyu Huo; Hansong Deng
Journal:  iScience       Date:  2021-05-12

8.  Enzyme replacement therapy for pancreatic insufficiency: present and future.

Authors:  Aaron Fieker; Jessica Philpott; Martine Armand
Journal:  Clin Exp Gastroenterol       Date:  2011-05-04

9.  In vitro Comparison of Pancreatic Enzyme Preparations Available in the Indian Market.

Authors:  Shailesh V Shrikhande; V G Mohan Prasad; J Enrique Domínguez-Muñoz; Kevin E Weigl; Kushal D Sarda
Journal:  Drug Des Devel Ther       Date:  2021-09-07       Impact factor: 4.162

10.  Challenges in the management of pancreatic exocrine insufficiency.

Authors:  Benjamin Myles Shandro; Rani Nagarajah; Andrew Poullis
Journal:  World J Gastrointest Pharmacol Ther       Date:  2018-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.